Pharmadax
NDC Database

Pharmadax

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 4
  • Latest Marketing Date 2020-12-01
  • Data Source FDA
  • First Marketing Date 2020-11-20
Company Overview

Company

Pharmadax

Country

Taiwan

Website

Visit Website

Email

mail@pharmadax.com

Social Profiles

LinkedIn
Company Snapshot

Pharmadax

5F-1, No.236, Liancheng Rd, ZhongheDist, New Taipei City 235

Taiwan

www.pharmadax.com.cn/English/Enlish.html mail@pharmadax.com View on Map
NDC Records ( 4 records )
2020
20 Nov
Drug for Further Processing NDC: 60050-001

Nonproprietary Name

Metoprolol Succinate

Dosage Form

TABLET, EXTENDED RELEASE

Strength

25 mg/1

Labeler

Pharmadax Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

60050-001

Substance

METOPROLOL SUCCINATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-11-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
20 Nov
Drug for Further Processing NDC: 60050-002

Nonproprietary Name

Metoprolol Succinate

Dosage Form

TABLET, EXTENDED RELEASE

Strength

50 mg/1

Labeler

Pharmadax Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

60050-002

Substance

METOPROLOL SUCCINATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-11-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
01 Dec
Drug for Further Processing NDC: 60050-003

Nonproprietary Name

Metoprolol Succinate

Dosage Form

TABLET, EXTENDED RELEASE

Strength

100 mg/1

Labeler

Pharmadax Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

60050-003

Substance

METOPROLOL SUCCINATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2020
01 Dec
Drug for Further Processing NDC: 60050-004

Nonproprietary Name

Metoprolol Succinate

Dosage Form

TABLET, EXTENDED RELEASE

Strength

200 mg/1

Labeler

Pharmadax Inc

Marketing Category

DRUG FOR FURTHER PROCESSING

60050-004

Substance

METOPROLOL SUCCINATE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2020-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    17 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

60050-001

Nonproprietary Name

Metoprolol Succinate

Labeler

Pharmadax Inc

Dosage Form

TABLET, EXTENDED RELEASE

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit